NIH #P50CA210964
Project 1: Fibrolamellar HCC
- Amount
- $400K–$500K
- Period
- 2018-09-10 → 2024-08-31
- PIs
- 1
Awarded at MAYO CLINIC ROCHESTER
Michael Torbenson
Full Professor(heuristic)
Liver Disease Diagnosis and Treatment · Epidemiology
Compare more Epidemiology professors.
h-index100
i10-index300
Publications460
Citations74,461
Grants
3 total · 0 active
NIH #R01DK078686
Genetic and epigenetic regulation of Hepatitis B contributes to liver cancer
- Amount
- $300K–$400K
- Period
- 2008-01-15 → 2011-11-30
- PIs
- 1
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #K08DA016370
Occult Hepatitis B
- Amount
- $100K–$200K
- Period
- 2003-09-30 → 2008-06-30
- PIs
- 1
Awarded at JOHNS HOPKINS UNIVERSITY
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Supplementary Data 3 from Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB12026-06-17
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-01
Data may not be current
Find elsewhere
ORCID: 0000-0002-8334-7725